MedPath

Online group and peer support speech therapy for people with progressive ataxia

Not Applicable
Completed
Conditions
Progressive ataxia
Nervous System Diseases
Registration Number
ISRCTN93368860
Lead Sponsor
niversity of Strathclyde
Brief Summary

2022 Results article in https://doi.org/10.1007/s12311-022-01462-9 (added 16/12/2022)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
9
Inclusion Criteria

1. People with progressive ataxia and associated mild to moderate dysarthria
2. The lower age limit will be 16 years
3. Participants require adequate vision and hearing to participate in the prescribed activities

Exclusion Criteria

1. Other medical conditions
2. Speech and language impairments beyond those associated with their ataxia

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<br> 1. Speech data evaluated acoustically (sustained vowel length) as well as perceptually by naïve listeners (voice quality, intelligibility and naturalness) across all four assessment points<br> 2. Patient perceptions of therapy outcomes and delivery format assessed using qualitatively analysed interview data from assessment 3<br>
Secondary Outcome Measures
NameTimeMethod
<br> 1. Fatigue measured using the Fatigue Rating Scale at assessments 1 and 3<br> 2. Attendance patterns measured using attendance records during the 6-week intervention period<br> 3. Need for additional sessions measured using attendance records during the 6-week intervention period<br>
© Copyright 2025. All Rights Reserved by MedPath